Tag: VascuCel
Admedus sells CardioCel and VacsuCel to focus on TAVI
Admedus has sold the distribution rights to its CardioCel and VascuCel product range for $A36.2 million to US-based LeMaitre Vascular. A press release from...
US FDA clears Admedus Vascucel
Admedus Limited has received US Food and Drug Administration (FDA) 510(k) clearance to market VascuCel.
“The FDA clearance for VascuCel is important for Admedus as...
Admedus set to launch vascular product
Admedus announced on 25 August 2016 that the manufacturing team have met the internal timeline of being prepared for the manufacture of VascuCel for...
